Patent ID: 8883199
Filing Date: 2014-11-11
Classification: A61K,A61N,A61P

Abstract:
1. A method of treating cancer in a subject in need thereof; comprising administration of an effective amount of N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamine of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base; alone or in combination with a surgery, chemotherapy, hormone therapy treatment or radiotherapy. wherein the compound of formula (I), or an addition salt thereof with a pharmaceutically acceptable acid or base. is administered for 4 consecutive days, that period being followed by 3 consecutive days without any administration of the compound of formula (I), or an addition salt thereof with a pharmaceutically acceptable acid or base, with the proviso that the chemotherapy is not FOLFOX (oxaliplatin/folinic acid/5-fluorouracil).